Real-World Experience and Optimization of Outpatient Chimeric Antigen Receptor T Cell Therapy
Transplant Cell Ther
.
2022 Sep;28(9):583-585.
doi: 10.1016/j.jtct.2022.06.021.
Epub 2022 Jun 30.
Authors
Mary McGann
1
,
James A Davis
2
,
Kelly J Gaffney
2
,
Deidra Smith
2
,
Kathy Edwards
2
,
Brian T Hess
2
,
Hamza Hashmi
2
Affiliations
1
Medical University of South Carolina, Charleston, South Carolina. Electronic address: mcgannm@musc.edu.
2
Medical University of South Carolina, Charleston, South Carolina.
PMID:
35781100
DOI:
10.1016/j.jtct.2022.06.021
No abstract available
Publication types
Comment
MeSH terms
Cell- and Tissue-Based Therapy
Humans
Immunotherapy, Adoptive
Outpatients
Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen*
Substances
Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen